Elsevier

The Annals of Thoracic Surgery

Volume 84, Issue 6, December 2007, Pages 2070-2075
The Annals of Thoracic Surgery

Original article
Cardiovascular
Two Thousand Blalock-Taussig Shunts: A Six-Decade Experience

Presented at the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.
https://doi.org/10.1016/j.athoracsur.2007.06.067Get rights and content

Background

The Blalock-Taussig shunt (BTS) remains valuable for palliation of congenital heart disease, but its role has evolved. We reviewed our total institutional experience with BTS to examine changes in its use and outcomes.

Methods

A retrospective review was performed of all patients undergoing BTS at our institution from November 1944 to May 2006. Hospital records and autopsy records were evaluated to determine patient demographics, diagnoses, operative data, hospital complications, and long-term outcomes.

Results

During the last 62 years, 2,016 BTS were performed by 28 surgeons on 1,880 patients from 35 countries. Classic BTS were performed in 75% (1,503 of 2,016 BTS). Diagnosis was tetralogy of Fallot in 72% (1,294 of 1,802), although diagnoses were imprecise in the early part of the series. Overall operative mortality was 14% (227 of 1,574). On follow-up, 32% of tetralogy of Fallot patients (411 of 1,294 patients) underwent subsequent total correction at our institution, and an additional 116 patients for whom follow-up was available had total correction of tetralogy of Fallot at other institutions, a combined total correction of tetralogy of Fallot rate of 41%. Of patients with complex congenital heart defects, 26% (106 of 404 patients) had subsequent cavopulmonary connection or atrial or arterial switch procedures. A comparison of the first and second halves of the series revealed several trends: decreasing mean annual number of BTS (66/year versus 9/year, respectively), decreasing operative mortality (16% versus 9%), and increasing proportion of single-ventricle diagnoses (5% versus 34%).

Conclusions

Evolution of the BTS has seen a decrease in overall use, particularly in tetralogy of Fallot, but greater application to single-ventricle cardiac lesions and improved operative survival.

Section snippets

Patient Selection

After obtaining institutional review board approval and waiver of consent, retrospective review was performed of all patients undergoing the BTS procedure at The Johns Hopkins Hospital from November 1944 through May 2006. All patients who underwent some form of systemic to pulmonary shunting procedure were included, regardless of whether this was a part of a larger procedure or set of procedures. The exceptions were patients undergoing central shunts, such as Potts or Waterston shunts. The list

Patients

During the last 62 years, 2,016 BTS were performed by 28 surgeons on 1,880 patients from 35 countries. Data were available on 94.4% (1,774 of 1,880) of patients in this series. Diagnosis was tetralogy of Fallot (TOF) in 72% (1,294 of 1,802), although diagnoses were imprecise in the early part of the series. One hundred sixty patients (9%) had single-ventricle diagnoses and typically had BTS as part of a complex palliative procedure. The percentage of patients undergoing BTS for single-ventricle

Comment

In the early 1970s, Taussig and colleagues [3] first reported long-term results of BTS at our institution. The 12% operative mortality, combined with a 23% late mortality at 15 years, set the standard for surgical palliation of patients with TOF. Although results were inferior for patients with tricuspid atresia [4], truncus arteriosus [5], and transposition of the great vessels [6], the success with these disorders nonetheless demonstrated promise for treatment of many forms of cyanotic heart

References (40)

  • M. de Leval et al.

    Modified Blalock-Taussig shunt: use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts

    J Thorac Cardiovasc Surg

    (1981)
  • R. Ullom et al.

    The Blalock-Taussig shunt in infants: standard versus modified

    Ann Thorac Surg

    (1987)
  • E. Bove et al.

    Subclavian-pulmonary artery shunts with polytetrafluoroethylene interposition grafts

    Ann Thorac Surg

    (1984)
  • A. Blalock et al.

    The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia

    JAMA

    (1945)
  • T.V. Brogan et al.

    Has the time come to rename the Blalock-Taussig shunt?

    Pediatr Crit Care Med

    (2003)
  • H.B. Taussig et al.

    Long-time observations on the Blalock-Taussig operationI. Results of first operation

    Johns Hopkins Med J

    (1971)
  • H.B. Taussig et al.

    Long-time observations on the Blalock-Taussig operationIV. Tricuspid atresia

    Johns Hopkins Med J

    (1973)
  • H.B. Taussig et al.

    Long-time observations on the Blalock-Taussig operationVI. Truncus arteriosus IV

    Johns Hopkins Med J

    (1973)
  • H.B. Taussig et al.

    Long-time observations on the Blalock-Taussig operationVII. Transposition of the great vessels and pulmonary stenosis

    Johns Hopkins Med J

    (1974)
  • K.A. Murdison et al.

    Hypoplastic left heart syndromeOutcome after initial reconstruction and before modified Fontan procedure

    Circulation

    (1990)
  • Cited by (100)

    View all citing articles on Scopus
    View full text